Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$0.49 - $0.82 $121 - $202
247 New
247 $0
Q2 2022

Aug 12, 2022

SELL
$0.8 - $1.5 $9,530 - $17,869
-11,913 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.24 - $2.75 $97,255 - $215,688
-78,432 Reduced 86.81%
11,913 $17,000
Q4 2021

Feb 14, 2022

BUY
$2.42 - $3.65 $135,478 - $204,337
55,983 Added 162.92%
90,345 $226,000
Q3 2021

Nov 09, 2021

BUY
$2.82 - $3.7 $71,340 - $93,602
25,298 Added 279.1%
34,362 $110,000
Q2 2021

Aug 13, 2021

SELL
$3.5 - $5.48 $163,866 - $256,568
-46,819 Reduced 83.78%
9,064 $32,000
Q1 2021

May 13, 2021

BUY
$3.16 - $4.89 $108,403 - $167,751
34,305 Added 158.98%
55,883 $198,000
Q4 2020

Feb 11, 2021

SELL
$2.2 - $4.45 $15,697 - $31,750
-7,135 Reduced 24.85%
21,578 $68,000
Q3 2020

Nov 12, 2020

SELL
$2.62 - $4.78 $7,993 - $14,583
-3,051 Reduced 9.61%
28,713 $116,000
Q2 2020

Aug 12, 2020

BUY
$1.83 - $3.16 $58,128 - $100,374
31,764 New
31,764 $85,000
Q1 2020

May 13, 2020

SELL
$1.14 - $2.96 $1 - $2
-1 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$1.25 - $2.57 $1 - $2
1 New
1 $0
Q3 2019

Nov 14, 2019

SELL
$1.26 - $1.96 $3,374 - $5,248
-2,678 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$1.43 - $1.94 $10,912 - $14,804
-7,631 Reduced 74.02%
2,678 $4,000
Q1 2019

May 15, 2019

BUY
$0.94 - $2.47 $9,690 - $25,463
10,309 New
10,309 $18,000
Q4 2018

Feb 14, 2019

SELL
$0.57 - $1.53 $7,473 - $20,061
-13,112 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$1.44 - $3.13 $15,291 - $33,237
10,619 Added 425.95%
13,112 $21,000
Q2 2018

Aug 14, 2018

SELL
$2.92 - $5.1 $16,118 - $28,151
-5,520 Reduced 68.89%
2,493 $7,000
Q1 2018

May 15, 2018

BUY
$3.42 - $5.35 $9,480 - $14,830
2,772 Added 52.89%
8,013 $37,000
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.84 $14,598 - $21,673
4,478 Added 586.89%
5,241 $21,000
Q3 2017

Nov 14, 2017

BUY
$3.83 - $4.89 $2,922 - $3,731
763
763 $3,000

Others Institutions Holding FBIO

About Fortress Biotech, Inc.


  • Ticker FBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,735,000
  • Market Cap $155M
  • Description
  • Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...
More about FBIO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.